Atharva Kale is a final year University of Sydney PhD student at The Westmead Institute for Medical Research. Her project is on improving beta cell function and islet transplantation outcomes by modulating a protein called CD47.
When | Session | Talk Title | Room |
---|---|---|---|
Wed-25 13:40 - 15:10 |
Abstract Session — Islet transplantation | Targeting CD47 improves islet function and survival | Beylerbeyi 1 |